Where is 1life Healthcare Inc (ONEM) stock falling in the health information services space after falling -0.23% this week?

Hill 62 InvestorsObserver lifts 1life Healthcare Inc (ONEM) shares to the top of the health information services industry. In addition to scoring more than 83% of stocks in the health information services sector, ONEM’s overall rating of 62 means the stock scores better than 62% of all stocks.

ONEM has an overall rating of 62. Find out what this means for you and get the rest of the ranking on ONEM!

What do these notes mean?

Stock analysis can be difficult. There are tons of numbers and ratios out there, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We categorize most of our scores by percentiles to make it easier for investors to understand. A score of 62 means the stock is more attractive than 62% of stocks. Our proprietary rating system captures technical factors, fundamental analysis and the opinions of Wall Street analysts. This makes InvestorsObserverThe overall rating of is a great way to start, regardless of your investing style. Scores ranked in percentiles are also easy to understand. A score of 100 is high and a 0 is low. There’s no need to try to remember what’s “good” for a bunch of complicated ratios, just pay attention to the higher numbers.

What’s going on with 1life Healthcare Inc stock today?

1life Healthcare Inc (ONEM) stock is up 0.06% while the S&P 500 fell -1.45% at 3:34 p.m. Friday, September 2. ONEM was up $0.01 from the previous closing price of $17.34 on volume of 1,827,373 shares. Over the past year, the S&P 500 has fallen -13.83% while the ONEM has fallen -27.98%. ONEM lost -$1.96 per share over the last 12 months. Click here for the full 1life Healthcare Inc stock report.

Stay in the know

Subscribe to our daily morning update newsletter and never miss market news, moves and more.

Thank you for signing up! You are ready to receive the Morning Update newsletter

Comments are closed.